Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

The impact of a history of asthma on long-term outcomes of people with newly diagnosed chronic obstructive pulmonary disease: A population study.

Kendzerska T, To TM, Aaron SD, Lougheed MD, Sadatsafavi M, FitzGerald JM, Gershon AS; Canadian Respiratory Research Network.

J Allergy Clin Immunol. 2017 Mar;139(3):835-843. doi: 10.1016/j.jaci.2016.06.026. Epub 2016 Sep 15.

PMID:
27641119
2.

Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.

Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M.

J Manag Care Pharm. 2008 Mar;14(2):176-85.

3.

Asthma and chronic obstructive pulmonary disease (COPD) prevalence and health services use in Ontario Métis: a population-based cohort study.

Gershon AS, Khan S, Klein-Geltink J, Wilton D, To T, Crighton EJ, Pigeau L, Macquarrie J, Allard Y, Russell SJ, Henry DA.

PLoS One. 2014 Apr 23;9(4):e95899. doi: 10.1371/journal.pone.0095899. eCollection 2014.

4.

Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.

Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA.

Am J Geriatr Pharmacother. 2009 Oct;7(5):262-70. doi: 10.1016/j.amjopharm.2009.11.003.

PMID:
19948302
5.

Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.

Gershon AS, Campitelli MA, Croxford R, Stanbrook MB, To T, Upshur R, Stephenson AL, Stukel TA.

JAMA. 2014 Sep 17;312(11):1114-21. doi: 10.1001/jama.2014.11432.

PMID:
25226477
6.

Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: A population study of prevalence, incidence and mortality.

Kendzerska T, Sadatsafavi M, Aaron SD, To TM, Lougheed MD, FitzGerald JM, Gershon AS; Canadian Respiratory Research Network.

PLoS One. 2017 Mar 16;12(3):e0173830. doi: 10.1371/journal.pone.0173830. eCollection 2017.

7.

History of Asthma in Patients with Chronic Obstructive Pulmonary Disease. A Comparative Study of Economic Burden.

Sadatsafavi M, Tavakoli H, Kendzerska T, Gershon A, To T, Aaron SD, FitzGerald JM; Canadian Respiratory Research Network.

Ann Am Thorac Soc. 2016 Feb;13(2):188-96. doi: 10.1513/AnnalsATS.201508-507OC.

PMID:
26599154
8.
9.

The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.

Huang JY, Jian ZH, Ndi Nfor O, Jhang KM, Ku WY, Ko PC, Jan SR, Ho CC, Lung CC, Pan HH, Liang YC, Liaw YP.

PLoS One. 2015 Jul 21;10(7):e0133367. doi: 10.1371/journal.pone.0133367. eCollection 2015.

10.

Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma.

Lee TA, Weaver FM, Weiss KB.

J Gen Intern Med. 2007 Jan;22(1):62-7.

12.

Famine in the young and risk of later hospitalization for COPD and asthma.

van Abeelen AF, Elias SG, de Jong PA, Grobbee DE, Bossuyt PM, van der Schouw YT, Roseboom TJ, Uiterwaal CS.

PLoS One. 2013 Dec 23;8(12):e82636. doi: 10.1371/journal.pone.0082636. eCollection 2013.

13.

Outcomes of patients with chronic obstructive pulmonary disease diagnosed with or without pulmonary function testing.

Gershon A, Mecredy G, Croxford R, To T, Stanbrook MB, Aaron SD; Canadian Respiratory Research Network.

CMAJ. 2017 Apr 10;189(14):E530-E538. doi: 10.1503/cmaj.151420. Epub 2016 Nov 14.

14.

The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population.

de Marco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M, Casali L, Ferrari M, Nicolini G, Panico MG, Pirina P, Zanolin ME, Cerveri I, Verlato G.

PLoS One. 2013 May 10;8(5):e62985. doi: 10.1371/journal.pone.0062985. Print 2013.

15.

Mortality among subjects with chronic obstructive pulmonary disease or asthma at two respiratory disease clinics in Ontario.

Finkelstein MM, Chapman KR, McIvor RA, Sears MR.

Can Respir J. 2011 Nov-Dec;18(6):327-32.

16.

Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.

Brooks TW, Creekmore FM, Young DC, Asche CV, Oberg B, Samuelson WM.

Pharmacotherapy. 2007 May;27(5):684-90.

PMID:
17461703
17.

Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma.

Menezes AMB, Montes de Oca M, Pérez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, Muiño A, Jardim JRB, Valdivia G, Tálamo C; PLATINO Team.

Chest. 2014 Feb;145(2):297-304. doi: 10.1378/chest.13-0622.

PMID:
24114498
18.

In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.

Ho TW, Tsai YJ, Ruan SY, Huang CT, Lai F, Yu CJ; HINT Study Group.

PLoS One. 2014 Dec 9;9(12):e114866. doi: 10.1371/journal.pone.0114866. eCollection 2014.

19.

Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study.

Gershon AS, Warner L, Cascagnette P, Victor JC, To T.

Lancet. 2011 Sep 10;378(9795):991-6. doi: 10.1016/S0140-6736(11)60990-2.

PMID:
21907862
20.

Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION).

Mentz RJ, Schulte PJ, Fleg JL, Fiuzat M, Kraus WE, Piña IL, Keteyian SJ, Kitzman DW, Whellan DJ, Ellis SJ, O'Connor CM.

Am Heart J. 2013 Feb;165(2):193-9. doi: 10.1016/j.ahj.2012.10.029. Epub 2012 Nov 28.

Supplemental Content

Support Center